Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

Approvals mean very little.

This is why I will continue to add:

I’m buying for the Approvals and Launches
There maybe other reasons investors buy shares of Elite
I have an open mind

SunGen ANDA #2 (The Avatar) undisclosed CNS stimulant $1.6 Billion market only 3 competitors to the name brand.
Elite will split the Generic money with 3 competitors.

FDA busy reviewing submission currently.
We have 10-12 months to take advantage before Approval.

This helpful info contributed to the board by N2K shows an average amount we might receive. It could be MUCH more due to so few competitors.

N2Ks contribution


For a product entering a growth market with existing product market leaders having more than a three year lead time, there has been a first year average market capture of 8.7%. If we extrapolate that to Elite and the CNS ER product for the $1.6 B market it is (that's right) $139.2 Million in the first year. And, with the Glenmark partnership as the commercialization engine, it could be better that the other two I found in my research, because Glenmark is more capable than the other two had as commercial partners.

ELTP